Aaron S. Kesselheim

False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications

Steven Woloshin, Neeraj G. Patel, Aaron S. Kesselheim · New England Journal of Medicine · 2020 · 906 citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +12

Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results

Thomas J. Hwang, Daniel Carpenter, Julie C. Lauffenburger et al. · JAMA Internal Medicine · 2016 · 440 citations

Pharmacy, Pharmacology, Clinical Pharmacology +16

FDA Approval and Regulation of Pharmaceuticals, 1983-2018

Jonathan J. Darrow, Jerry Avorn, Aaron S. Kesselheim · JAMA · 2020 · 362 citations

Pharmacy, Pharmaceutical Policy, Drug Law +15

Clinical Decision Support Systems Could Be Modified To Reduce ‘Alert Fatigue’ While Still Minimizing The Risk Of Litigation

Aaron S. Kesselheim, Kathrin Cresswell, Shobha Phansalkar et al. · Health Affairs · 2011 · 285 citations

Computing, Health Informatics, Risk Management +17

Regulation of Medical Devices in the United States and European Union

Daniel B. Kramer, Shuai Xu, Aaron S. Kesselheim · New England Journal of Medicine · 2012 · 263 citations

Engineering, Health Policy, Regulatory Policy +15